Truveta
Founded Year
2020Stage
Series C | AliveTotal Raised
$515MValuation
$0000Last Raised
$320M | 10 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+74 points in the past 30 days
About Truveta
Truveta specializes in electronic health record (EHR) data and analytics within the healthcare sector. The company provides EHR data solutions, including analytics and insights that support clinical research, therapy development, and public health initiatives. Truveta's services are used by life science, public health, and healthcare organizations. It was founded in 2020 and is based in Bellevue, Washington.
Loading...
ESPs containing Truveta
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The social determinants of health (SDOH) analytics & services market enables a deeper understanding of the non-medical factors that influence individual and population health outcomes. SDOH refers to social and economic factors such as income, education, housing, and access to healthcare that impact health disparities and outcomes. The SDOH analytics & services market provides solutions that lever…
Truveta named as Highflier among 12 other companies, including Unite Us, evermore, and Socially Determined.
Loading...
Research containing Truveta
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Truveta in 2 CB Insights research briefs, most recently on Apr 17, 2025.
Apr 17, 2025 report
State of Digital Health Q1’25 Report
Aug 21, 2024
The clinical trials tech market mapExpert Collections containing Truveta
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Truveta is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,309 items
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 50
150 items
2022's cohort of the most promising digital health startups transforming the healthcare industry. Winners were chosen based on several factors, including data submitted by the companies, proprietary Mosaic scores, company business models and momentum in the market.
Artificial Intelligence (AI)
20,894 items
Truveta Patents
Truveta has filed 7 patents.
The 3 most popular patent topics include:
- health informatics
- electronic health records
- information privacy
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/8/2022 | Health informatics, Electronic health records, Telehealth, Medical terminology, Information privacy | Application |
Application Date | 11/8/2022 |
|---|---|
Grant Date | |
Title | |
Related Topics | Health informatics, Electronic health records, Telehealth, Medical terminology, Information privacy |
Status | Application |
Latest Truveta News
Oct 30, 2025
Share Truveta is proud to announce the publication of its latest peer-reviewed research in Radiology Advances: “XComposition: Multimodal Deep Learning Model to Measure Body Composition Using Chest Radiographs and Clinical Data.” This groundbreaking study demonstrates the power of artificial intelligence to estimate critical body composition measures—such as visceral and subcutaneous fat volumes—from a simple chest radiograph combined with commonly available clinical data. The deep learning model is available as a Python library for others to experiment with in Truveta’s GitHub. Key findings The research team developed a multimodal deep learning model that integrates chest radiographs (CXR) with four basic clinical variables (age, s** at birth, height, and weight) to estimate body composition typically measured by CT scans. The study analyzed data from more than 1,100 patients across a subset of Truveta member health systems in the US. The multimodal model accurately estimated subcutaneous fat volume (Pearson’s R: 0.85) and visceral fat volume (Pearson’s R: 0.76). A late fusion strategy—combining imaging and clinical data at the decision level—yielded the best results (p < 0.04 for subcutaneous fat volume). The multimodal model outperformed imaging-only and clinical-only approaches across all key body composition metrics (p < 0.001 for subcutaneous fat volume). Why it matters Body composition is an important predictor of cardiovascular disease, diabetes, and cancer prognosis. Traditional methods to measure these metrics—such as MRI or CT—are expensive, resource-intensive, and not always accessible to patients. This study shows that a chest radiograph, one of the most common and widely available imaging tests, can serve as a low-cost, scalable tool for estimating body composition when combined with AI. “Our work shows that we can unlock clinically meaningful insights from a chest X-ray—an exam that millions of people receive each year,” said Ehsan Alipour, MD, PhD, a machine learning post-doctoral researcher at Truveta and lead author of the study. “By combining imaging with just a few simple clinical variables, we created a powerful, accessible way to estimate body composition that could help improve screening, research, and ultimately patient care.” This study leveraged Truveta Data, the most complete, timely, and representative dataset of de-identified electronic health records (EHR) in the US, contributed by a collective of leading health systems. Imaging data were linked with clinical variables across health systems, enabling the development and validation of this multimodal AI model.
Truveta Frequently Asked Questions (FAQ)
When was Truveta founded?
Truveta was founded in 2020.
Where is Truveta's headquarters?
Truveta's headquarters is located at 1745 114th Avenue South East, Bellevue.
What is Truveta's latest funding round?
Truveta's latest funding round is Series C.
How much did Truveta raise?
Truveta raised a total of $515M.
Who are the investors of Truveta?
Investors of Truveta include Providence, Regeneron, Henry Ford Health System, Advocate Health, Illumina and 9 more.
Who are Truveta's competitors?
Competitors of Truveta include Tasq.ai, Medicom, Atropos Health, Endimension, Dandelion and 7 more.
Loading...
Compare Truveta to Competitors
nference is a healthcare technology company specializing in clinical artificial intelligence (AI) and evidence. The company offers a platform that uses healthcare data to manage clinical data, support research, and work with patient outcomes through artificial intelligence. nference primarily serves the healthcare sector, providing solutions for clinical researchers, data scientists, and healthcare systems. It was founded in 2013 and is based in Cambridge, Massachusetts.
Commure provides artificial intelligence (AI) powered healthcare solutions within the health technology sector. The company offers products that automate and simplify provider, administrator, and patient workflows, including ambient clinical documentation, revenue cycle management, and remote patient monitoring. Commure serves the healthcare industry, with a focus on care delivery and operations for health systems. It was founded in 2017 and is based in Mountain View, California.
Zus Health focuses on healthcare data interoperability within the health tech industry. It offers a shared health data platform that facilitates access to patient data at the point of care, utilizing APIs, embedded components, and direct Electronic Health Record (EHR) integrations. The company's services are primarily targeted towards healthcare organizations looking to streamline patient care and data management processes. Zus Health was formerly known as Zeus Healthcare Technologies. It was founded in 2020 and is based in Boston, Massachusetts.
Owkin is an AI biotechnology company that employs artificial intelligence to improve drug discovery and development in the biopharmaceutical sector. The company specializes in AI-based identification of new treatments, clinical trial optimization, and diagnostic tool creation, while ensuring patient privacy through federated learning techniques. Owkin serves the biopharma and academic research communities. It was founded in 2016 and is based in New York, New York.
MDClone is a company that focuses on healthcare data analytics and synthetic data generation in the healthcare industry. Its offerings include a platform for healthcare data exploration, which organizations can use to gain insights from data. MDClone serves the health systems and life sciences sectors with its data solutions. It was founded in 2015 and is based in Beer-Sheva, Israel.
BriteCore operates as a cloud-native core insurance platform for property and casualty (P&C) insurers. The company offers services including policy administration, billing and claims management, product configuration, and access to reporting and analytics. BriteCore serves the insurance industry, providing solutions for insurers and managing general agents (MGAs). It was founded in 2009 and is based in Springfield, Missouri.
Loading...